The TRX-248 Transdermal System led to steady and continuous levels of treprostinil in the plasma over 24 hours and a low peak-to-trough fluctuation.
Exeltis USA, Inc. (Exeltis), a global pharmaceutical company specializing in women’s health, announced that the U.S. Food and ...
Vector Science & Therapeutics Corp. (TSXV: PAIN) today announced the filing of a provisional patent application covering a wearable transdermal delivery platform that uses a pulsed magnetic field to ...
Proprietary Magnetic Patch System Delivers Regenerative Peptides to Targeted Tissue Without Injection, with Built-In Confirmation of Successful Delivery MEQUON, Wis., June 30, 2026 /PRNewswire/ -- ...
International beauty brand SIMETRA has announced the launch of its first AI Smart Skin-Detection Mirror and Art-Infused Hair ...
Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. Nutriband ( (NTRB)) just unveiled an update. On June 1, 2026, Nutriband entered into an amended ...
The FDA approved an update to the labeled strength of Twirla, a weekly contraceptive patch, its manufacturer announced.The ...
Following a massive 162 percent surge in prescriptions and a major FDA label reversal, a critical shortage of estradiol ...
Glaukos has completed patient enrolment in its Phase II clinical trial evaluating GLK-321 for the treatment of Demodex ...
Here are four different ways to incorporate the practice into your lifestyle.
More than 2300 people were tracked and the findings have since been replicated in follow-up analyses ...